Literature DB >> 33535287

Vaccine Innovations - Past and Future.

Julie L Gerberding1, Barton F Haynes1.   

Abstract

Year:  2021        PMID： 33535287     DOI： 10.1056/NEJMp2029466

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Development of an in-house quantitative ELISA for the evaluation of different Covid-19 vaccines in humans.

Authors:  Mariem Gdoura; Fatma Ben Ghaloum; Meriem Ben Hamida; Wafa Chamsa; Henda Triki; Chokri Bahloul
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

2.  The development of China's vaccine industry in the past decade: the perspective from drug regulatory science.

Authors:  Guanjie Wang; Mingli Shao
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

Review 3.  COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines.

Authors:  Shagnik Chattopadhyay; Sayantee Hazra; Arman Kunwar Hansda; Biswajit Biswas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2022-03-15       Impact factor: 6.986

4.  Dermatomyositis post vaccine against SARS-COV2.

Authors:  Adolfo Camargo Coronel; Francisco Javier Jiménez Balderas; Horacio Quiñones Moya; Mario Raúl Hernández Zavala; Pedro Mandinabeitia Rodríguez; José Ramiro Hernández Vázquez; Sandy Zamora Zarco; Sergio De Jesús Aguilar Castillo
Journal:  BMC Rheumatol       Date:  2022-04-01

Review 5.  Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena.

Authors:  Vivek P Chavda; Rajashri Bezbaruah; Mansi Athalye; Palak K Parikh; Abu Sufiyan Chhipa; Snehal Patel; Vasso Apostolopoulos
Journal:  Viruses       Date:  2022-04-06       Impact factor: 5.818

Review 6.  Accelerated COVID-19 vaccine development: milestones, lessons, and prospects.

Authors:  Karin Bok; Sandra Sitar; Barney S Graham; John R Mascola
Journal:  Immunity       Date:  2021-08-03       Impact factor: 31.745
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.